FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113989522> ?p ?o ?g. }

• W2113989522 endingPage "310S" @default.
• W2113989522 startingPage "287S" @default.
• W2113989522 abstract "This chapter about hemorrhagic complications of anticoagulant treatment is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Bleeding is the major complication of anticoagulant therapy. The criteria for defining the severity of bleeding varies considerably between studies, accounting in part for the variation in the rates of bleeding reported. The major determinants of vitamin K antagonist-induced bleeding are the intensity of the anticoagulant effect, underlying patient characteristics, and the length of therapy. There is good evidence that vitamin K antagonist therapy, targeted international normalized ratio (INR) of 2.5 (range, 2.0 to 3.0), is associated with a lower risk of bleeding than therapy targeted at an INR > 3.0. The risk of bleeding associated with IV unfractionated heparin (UFH) in patients with acute venous thromboembolism (VTE) is < 3% in recent trials. This bleeding risk may increase with increasing heparin dosages and age (> 70 years). Low molecular weight heparin (LMWH) is associated with less major bleeding compared with UFH in acute VTE. UFH and LMWH are not associated with an increase in major bleeding in ischemic coronary syndromes, but are associated with an increase in major bleeding in ischemic stroke. Information on bleeding associated with the newer generation of antithrombotic agents has begun to emerge. In terms of treatment decision making for anticoagulant therapy, bleeding risk cannot be considered alone, ie, the potential decrease in thromboembolism must be balanced against the potential increased bleeding risk." @default.
• W2113989522 created "2016-06-24" @default.
• W2113989522 creator A5002200808 @default.
• W2113989522 creator A5013493617 @default.
• W2113989522 creator A5014971710 @default.
• W2113989522 creator A5083115765 @default.
• W2113989522 creator A5088320381 @default.
• W2113989522 date "2004-09-01" @default.
• W2113989522 modified "2023-09-26" @default.
• W2113989522 title "Hemorrhagic Complications of Anticoagulant Treatment" @default.
• W2113989522 cites W107120791 @default.
• W2113989522 cites W1260428 @default.
• W2113989522 cites W131809637 @default.
• W2113989522 cites W1415814174 @default.
• W2113989522 cites W1498265361 @default.
• W2113989522 cites W1522694313 @default.
• W2113989522 cites W1558642892 @default.
• W2113989522 cites W156816327 @default.
• W2113989522 cites W1581187193 @default.
• W2113989522 cites W1583091879 @default.
• W2113989522 cites W1585004555 @default.
• W2113989522 cites W1586895761 @default.
• W2113989522 cites W1592274831 @default.
• W2113989522 cites W1647537909 @default.
• W2113989522 cites W1738640266 @default.
• W2113989522 cites W1851325607 @default.
• W2113989522 cites W1875541132 @default.
• W2113989522 cites W1884186391 @default.
• W2113989522 cites W1918936479 @default.
• W2113989522 cites W1954469645 @default.
• W2113989522 cites W1957588549 @default.
• W2113989522 cites W1967937963 @default.
• W2113989522 cites W1968470871 @default.
• W2113989522 cites W1969266021 @default.
• W2113989522 cites W1970472124 @default.
• W2113989522 cites W1972452854 @default.
• W2113989522 cites W1972706485 @default.
• W2113989522 cites W1973752977 @default.
• W2113989522 cites W1975170689 @default.
• W2113989522 cites W1976237679 @default.
• W2113989522 cites W1978193003 @default.
• W2113989522 cites W1978506115 @default.
• W2113989522 cites W1979245531 @default.
• W2113989522 cites W1979288586 @default.
• W2113989522 cites W1979363567 @default.
• W2113989522 cites W1981746689 @default.
• W2113989522 cites W1981816788 @default.
• W2113989522 cites W1982830772 @default.
• W2113989522 cites W1984307144 @default.
• W2113989522 cites W1984597181 @default.
• W2113989522 cites W1984833612 @default.
• W2113989522 cites W1986174344 @default.
• W2113989522 cites W1987034302 @default.
• W2113989522 cites W1989192399 @default.
• W2113989522 cites W1991549653 @default.
• W2113989522 cites W1992377235 @default.
• W2113989522 cites W1992460911 @default.
• W2113989522 cites W1993535521 @default.
• W2113989522 cites W1994894525 @default.
• W2113989522 cites W1995192108 @default.
• W2113989522 cites W1997667641 @default.
• W2113989522 cites W1999206854 @default.
• W2113989522 cites W1999810593 @default.
• W2113989522 cites W2003915795 @default.
• W2113989522 cites W2004337162 @default.
• W2113989522 cites W2004423916 @default.
• W2113989522 cites W2006587134 @default.
• W2113989522 cites W2007303097 @default.
• W2113989522 cites W2007650238 @default.
• W2113989522 cites W2009013630 @default.
• W2113989522 cites W2011532714 @default.
• W2113989522 cites W2012714913 @default.
• W2113989522 cites W2013749044 @default.
• W2113989522 cites W2015696505 @default.
• W2113989522 cites W2017836681 @default.
• W2113989522 cites W2019126121 @default.
• W2113989522 cites W2019678690 @default.
• W2113989522 cites W2025513998 @default.
• W2113989522 cites W2026550457 @default.
• W2113989522 cites W2026589095 @default.
• W2113989522 cites W2027151097 @default.
• W2113989522 cites W2027538725 @default.
• W2113989522 cites W2027568895 @default.
• W2113989522 cites W2027621199 @default.
• W2113989522 cites W2029345778 @default.
• W2113989522 cites W2029771152 @default.
• W2113989522 cites W2030262988 @default.
• W2113989522 cites W2031149324 @default.
• W2113989522 cites W2033724005 @default.
• W2113989522 cites W2034852521 @default.
• W2113989522 cites W2035545749 @default.
• W2113989522 cites W2037286121 @default.
• W2113989522 cites W2037998530 @default.
• W2113989522 cites W2040355051 @default.
• W2113989522 cites W2040404019 @default.
• W2113989522 cites W2040452288 @default.
• W2113989522 cites W204140586 @default.
• W2113989522 cites W2041709488 @default.

• next